Clinical trial
Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis
NCT00309660 · Herlev Hospital, Other · Unknown status
Key facts
| NCT number | NCT00309660 |
|---|---|
| Title | Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis |
| Lead sponsor | Herlev Hospital, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Drug |
| Interventions | Rosiglitazone |
| Enrollment | 20 |
| Start date | Nov 1, 2005 |
| Completion | Jun 1, 2007 |
| First posted | Apr 3, 2006 |
| Last update posted | Sep 21, 2006 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: